JP2002516273A5 - - Google Patents

Download PDF

Info

Publication number
JP2002516273A5
JP2002516273A5 JP2000550472A JP2000550472A JP2002516273A5 JP 2002516273 A5 JP2002516273 A5 JP 2002516273A5 JP 2000550472 A JP2000550472 A JP 2000550472A JP 2000550472 A JP2000550472 A JP 2000550472A JP 2002516273 A5 JP2002516273 A5 JP 2002516273A5
Authority
JP
Japan
Prior art keywords
formula
compound
pharmaceutical composition
amide
clearance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000550472A
Other languages
English (en)
Japanese (ja)
Other versions
JP4633927B2 (ja
JP2002516273A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/010948 external-priority patent/WO1999061012A2/en
Publication of JP2002516273A publication Critical patent/JP2002516273A/ja
Publication of JP2002516273A5 publication Critical patent/JP2002516273A5/ja
Application granted granted Critical
Publication of JP4633927B2 publication Critical patent/JP4633927B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000550472A 1998-05-22 1999-05-19 治療用ジヌクレオチドおよび誘導体 Expired - Fee Related JP4633927B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8654398P 1998-05-22 1998-05-22
US60/086,543 1998-05-22
PCT/US1999/010948 WO1999061012A2 (en) 1998-05-22 1999-05-19 Therapeutic dinucleotide and derivatives

Publications (3)

Publication Number Publication Date
JP2002516273A JP2002516273A (ja) 2002-06-04
JP2002516273A5 true JP2002516273A5 (cg-RX-API-DMAC7.html) 2006-07-13
JP4633927B2 JP4633927B2 (ja) 2011-02-16

Family

ID=22199276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000550472A Expired - Fee Related JP4633927B2 (ja) 1998-05-22 1999-05-19 治療用ジヌクレオチドおよび誘導体

Country Status (9)

Country Link
US (1) US6323187B1 (cg-RX-API-DMAC7.html)
EP (1) EP1087777B1 (cg-RX-API-DMAC7.html)
JP (1) JP4633927B2 (cg-RX-API-DMAC7.html)
CN (1) CN1301168A (cg-RX-API-DMAC7.html)
AT (1) ATE232733T1 (cg-RX-API-DMAC7.html)
AU (1) AU746750B2 (cg-RX-API-DMAC7.html)
CA (1) CA2332540A1 (cg-RX-API-DMAC7.html)
DE (1) DE69905464T2 (cg-RX-API-DMAC7.html)
WO (1) WO1999061012A2 (cg-RX-API-DMAC7.html)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319908B1 (en) 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en) 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
US7223744B2 (en) * 1997-02-10 2007-05-29 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
US6596725B2 (en) * 1997-02-10 2003-07-22 Inspire Pharmaceuticals, Inc. Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema
US6818629B2 (en) 1997-02-10 2004-11-16 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
US7078391B2 (en) * 1997-02-10 2006-07-18 Inspire Pharmaceuticals, Inc. Method of treating edematous retinal disorders
US6548658B2 (en) * 1997-07-25 2003-04-15 Inspire Pharmaceuticals, Inc. Di-(uridine 5′)-tetraphosphate and salts thereof
TW593331B (en) 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US6872710B2 (en) 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
CA2295515C (en) 1997-07-25 2006-03-14 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof
US6926911B1 (en) 1998-12-22 2005-08-09 The University Of North Carolina At Chapel Hill Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
EP2191718A1 (en) * 1998-12-22 2010-06-02 The University of North Carolina at Chapel Hill Compounds and uses for the treatment of airway diseases and for the delivery of airway drugs
JP4969002B2 (ja) * 1999-06-08 2012-07-04 ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン rAAV形質導入を増加するための化合物および方法
NZ516301A (en) * 1999-06-30 2003-07-25 Yamasa Corp Dinucleotide crystals
US7241447B1 (en) * 1999-10-07 2007-07-10 University Of Iowa Research Foundation Adeno-associated virus vectors and uses thereof
US6864243B1 (en) * 2000-05-12 2005-03-08 Inspire Pharmaceuticals, Inc. Method for treating retinal degeneration with purinergic receptor agonists
AU2001260643B9 (en) 2000-05-30 2006-10-19 Merck Sharp & Dohme Corp. Ectocornea extension promoters
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US6897201B2 (en) * 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7132408B2 (en) 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
WO2003000056A1 (en) * 2001-06-25 2003-01-03 Inspire Pharmaceuticals, Inc. Joint lubrication with p2y purinergic receptor agonists
MXPA04004215A (es) 2001-11-06 2004-07-08 Inspire Pharmaceuticals Inc Metodo para el tratamiento o la prevencion de enfermedades inflamatorias.
US7084128B2 (en) 2002-01-18 2006-08-01 Inspire Pharmaceuticals, Inc. Method for reducing intraocular pressure
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
WO2004089423A2 (en) * 2003-03-31 2004-10-21 University Of Iowa Research Foundation Pharmico-gene theraphy of epithelial sodium channel associated disoders
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20050131224A1 (en) * 2003-12-15 2005-06-16 Cti Pet Systems, Inc. Method for preparing radiolabeled thymidine
GB0417886D0 (en) * 2004-08-11 2004-09-15 Univ Cardiff Method and means for enhanced pulmonary delivery
US7368439B2 (en) * 2005-06-15 2008-05-06 Bar - Ilan University Dinucleoside poly(borano)phosphate derivatives and uses thereof
US7851456B2 (en) * 2005-06-29 2010-12-14 Inspire Pharmaceuticals, Inc. P2Y6 receptor agonists for treating lung diseases
EP1941883A1 (en) * 2007-01-08 2008-07-09 Universität Heidelberg Use of sodium blockers for an early therapy of obstructive lung diseases
WO2010088191A1 (en) * 2009-01-27 2010-08-05 Teleflex Medical Incorporated Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
HUE032891T2 (hu) 2012-12-17 2017-11-28 Parion Sciences Inc Klórpirazin-karboxamid-származékok nem kielégítõ nyálkahártya-hidratáció által elõsegített megbetegedések kezelésére
RU2671976C2 (ru) 2012-12-17 2018-11-08 Пэрион Сайенсиз, Инк. Соединения 3,5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
CN103923143B (zh) * 2014-04-10 2017-01-11 江西科技师范大学 一种合成双核苷四磷酸以及p2,p3-(双卤代)亚甲基双核苷四磷酸的方法
WO2017139381A1 (en) 2016-02-08 2017-08-17 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
WO2017155973A1 (en) 2016-03-07 2017-09-14 University Of Iowa Research Foundation Aav-mediated expression using a synthetic promoter and enhancer
US12173305B2 (en) 2016-05-26 2024-12-24 University Of Iowa Research Foundation cis and trans requirements for terminal resolution of human bocavirus 1
US11142775B2 (en) 2017-01-13 2021-10-12 University Of Iowa Research Foundation Bocaparvovirus small noncoding RNA and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292498A (en) 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
US5635160A (en) 1995-06-07 1997-06-03 The University Of North Carolina At Chapel Hill Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
US5900407A (en) * 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds
US5837861A (en) * 1997-02-10 1998-11-17 Inspire Pharmaceuticals, Inc. Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
EP0981534B1 (en) * 1997-02-06 2006-05-03 Inspire Pharmaceuticals, Inc. Dinucleotides and their uses
US6060327A (en) * 1997-05-14 2000-05-09 Keensense, Inc. Molecular wire injection sensors
KR20010040559A (ko) * 1998-02-02 2001-05-15 시그나츄어 바이오사이언스 인코포레이티드 분자 결합 이벤트의 검출용 방법 및 장치

Similar Documents

Publication Publication Date Title
JP4633927B2 (ja) 治療用ジヌクレオチドおよび誘導体
ATE325129T1 (de) Dinukleotide und ihre verwendungen
JP2002537329A5 (cg-RX-API-DMAC7.html)
JP4399478B2 (ja) 1−(2−(ヒドロキシメチル)−1,3−オキサチオラン−5−イル)−5−フルオロシトシンのb型肝炎治療への使用
JP2009539828A5 (cg-RX-API-DMAC7.html)
BR0015908A (pt) Emprego de compostos org nicos no tratamento de doenças
JP2009539882A5 (cg-RX-API-DMAC7.html)
JP2020512302A5 (cg-RX-API-DMAC7.html)
JP2002531498A5 (cg-RX-API-DMAC7.html)
JP2002533472A5 (cg-RX-API-DMAC7.html)
JP2002541233A5 (cg-RX-API-DMAC7.html)
JP2008505902A5 (cg-RX-API-DMAC7.html)
JP2002332234A5 (cg-RX-API-DMAC7.html)
BR9610059A (pt) Método para detectar doença pulmomar
JP2001521187A5 (cg-RX-API-DMAC7.html)
JP2003306481A5 (cg-RX-API-DMAC7.html)
JP2004509837A5 (cg-RX-API-DMAC7.html)
ME02218B (me) Jedinjenja piruvamida kao inhibitori peptidaza alergena grinja grupe 1
US6555675B2 (en) Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
JP2001520994A5 (cg-RX-API-DMAC7.html)
JP2002506864A5 (cg-RX-API-DMAC7.html)
JP2006510659A5 (cg-RX-API-DMAC7.html)
JP2006524677A5 (cg-RX-API-DMAC7.html)
JP2003534318A5 (cg-RX-API-DMAC7.html)
JP2009528259A5 (cg-RX-API-DMAC7.html)